TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
18 hedge funds and large institutions have $1.14M invested in Titan Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
4
Closed
5
Calls
$45K
Puts
–
Net Calls
+$45K
Net Calls Change
+$39K
Top Buyers
| 1 |
Truist Financial
Charlotte,
North Carolina
|
+$675K |
| 2 |
State Street
Boston,
Massachusetts
|
+$41K |
| 3 |
FIA
FNY Investment Advisers
New York
|
+$30K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.54K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$103K |
| 2 |
Millennium Management
New York
|
-$49.7K |
| 3 |
VF
Virtu Financial
New York
|
-$37.2K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$33K |
| 5 |
HF
HRT Financial
New York
|
-$29K |
